Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
- PMID: 26461092
- PMCID: PMC4646058
- DOI: 10.1016/j.ccell.2015.09.002
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Abstract
Glioblastomas display hierarchies with self-renewing cancer stem-like cells (CSCs). RNA sequencing and enhancer mapping revealed regulatory programs unique to CSCs causing upregulation of the iron transporter transferrin, the top differentially expressed gene compared with tissue-specific progenitors. Direct interrogation of iron uptake demonstrated that CSCs potently extract iron from the microenvironment more effectively than other tumor cells. Systematic interrogation of iron flux determined that CSCs preferentially require transferrin receptor and ferritin, two core iron regulators, to propagate and form tumors in vivo. Depleting ferritin disrupted CSC mitotic progression, through the STAT3-FoxM1 regulatory axis, revealing an iron-regulated CSC pathway. Iron is a unique, primordial metal fundamental for earliest life forms, on which CSCs have an epigenetically programmed, targetable dependence.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







References
-
- De Arriba Zerpa GA, Saleh MC, Fernández PM, Guillou F, Espinosa de los Monteros A, de Vellis J, Zakin MM, Baron B. Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line. J Neurosci Res. 2000;61:388–395. - PubMed
-
- Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006a;444:756–760. - PubMed
-
- Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006b;66:7843–7848. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
- R01 CA169117/CA/NCI NIH HHS/United States
- P30CA177558/CA/NCI NIH HHS/United States
- K99/R00 CA157948/CA/NCI NIH HHS/United States
- P20 RR020171/RR/NCRR NIH HHS/United States
- R01 NS083629/NS/NINDS NIH HHS/United States
- R21 CA198254/CA/NCI NIH HHS/United States
- P01 HL076491/HL/NHLBI NIH HHS/United States
- T32 CA059366/CA/NCI NIH HHS/United States
- R01 DK083359/DK/NIDDK NIH HHS/United States
- Canadian Institutes of Health Research/Canada
- T32 GM008056/GM/NIGMS NIH HHS/United States
- P30 CA177558/CA/NCI NIH HHS/United States
- K08 CA155764/CA/NCI NIH HHS/United States
- R01 CA171652/CA/NCI NIH HHS/United States
- R01 NS089272/NS/NINDS NIH HHS/United States
- F32 CA189647/CA/NCI NIH HHS/United States
- R21 CA191263/CA/NCI NIH HHS/United States
- R01 NS087913/NS/NINDS NIH HHS/United States
- T32 TRN508838/PHS HHS/United States
- F30 CA183510/CA/NCI NIH HHS/United States
- 2P20 RR020171/RR/NCRR NIH HHS/United States
- T32 GM007250/GM/NIGMS NIH HHS/United States
- R01 CA154130/CA/NCI NIH HHS/United States
- P01 HL029582/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous